Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,007 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis

NCT01633372

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Birmingham Hematology Oncology Associates, LLC Birmingham, Alabama, United States
  • Mayo Clinic, Arizona Scottsdale, Arizona, United States
  • UCLA Hematology & Oncology Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
View all 22 locations
View Trial Details
Completed

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

NCT01814475

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +8 more
Locations
  • Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy
  • Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy
  • Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy
  • AO Spedali Civili di Brescia- USD - TMO Adulti Brescia, Italy
View all 21 locations
View Trial Details
Completed

Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)

NCT03469661

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Complejo Hospitalario de A Coruña A Coruña, Spain
  • Hospital de Burgos Burgos, Spain
  • Hospital Universitario Insular de Gran Canaria Las Palmas de Gran Canaria, Spain
  • Hospital Ramon y Cajal Madrid, Spain
View Trial Details
Completed

Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients

NCT00110266

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Univ of Alabama Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • Bay Area Cancer Research Group Concord, California, United States
  • City of Hope National Medical Center Duarte, California, United States
View all 48 locations
View Trial Details
Completed

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

NCT03647215

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +20 more
Locations
  • Limerick University Hospital Limerick, Dooradoyle, Ireland
  • University Hospital Waterford Waterford, Ireland
  • Royal Cornwall Hospital Truro, Cornwall, United Kingdom
  • Royal Devon & Exeter Hospital Exeter, Devon, United Kingdom
View all 33 locations
View Trial Details
Completed

Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

NCT00919503

Conditions
Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +51 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
  • Seattle Children's Hospital Seattle, Washington, United States
View Trial Details

Related conditions